Search results for "PHOSPHATASE"

showing 10 items of 499 documents

Selected enzyme activities in mouse cardiac muscle during training and terminated training

1984

We studied the effects of running-training, heavy exercise and termination of training on the heart weight, the ratio heart to body weight and the cardiac muscle activities of actomyosin ATPase, citrate synthase, succinate dehydrogenase, cytochrome c oxidase, malate dehydrogenase, adenylate kinase and beta-glucuronidase with adult male NMRI-mice. Stable hypertrophy (6-7%), estimated by the ratio heart or ventricle weight to body weight, was achieved by 28 exercises and it was dependent on the running speed (20 vs. 25 m X min-1). The withdrawal of training for 5-61 days did not permanently decrease the heart weight or the heart to body weight ratio to the level of sedentary controls. The act…

Malemedicine.medical_specialtyTime FactorsHeart diseasePhysiologyATPasePhysical ExertionCardiomegalyMice Inbred StrainsCitrate (si)-SynthaseBiologyMalate dehydrogenaseMitochondria HeartMuscle hypertrophyMicePhysiology (medical)Internal medicinemedicineAnimalsCitrate synthaseGlucuronidaseAdenosine TriphosphatasesCardiac muscleActomyosinmedicine.diseaseMyocardial ContractionMitochondria MuscleEndocrinologymedicine.anatomical_structureVentriclebiology.proteinHeart enlargementCardiology and Cardiovascular MedicineOxidation-ReductionBasic Research in Cardiology
researchProduct

Acid hydrolase activity in red and white skeletal muscle of mice during a two-week period following exhausting exercise

1978

The activities of beta-glucuronidase, beta-N-acetylglucosaminidase, arylsulphatase, ribonuclease, p-nitrophenylphosphatase, and malate dehydrogenase together with protein content were assayed from representative mixed (m. rectus femoris), predominantly red (proximal heads of m. vastus lateralis, m.v. medius and m. v. intermedius), and predominantly white (distal head of m. vastus lateralis) muscle homogenates of mice during a two-week period following one single exposure to exhausting intermittent running on a treadmill. The activities of cathepsin D and beta-glycerophosphatase were assayed from mixed muscle only. In all three muscle types, particularly in red muscle, the activities of beta…

Malemedicine.medical_specialtyTime FactorsHydrolasesPhysiologyAcid PhosphatasePhysical ExertionClinical BiochemistryPhosphataseCathepsin DBiologyMalate dehydrogenaseMiceRibonucleasesMalate DehydrogenasePhysiology (medical)Internal medicineAcetylglucosaminidasemedicineAnimalsTreadmillReceptorArylsulfatasesGlucuronidase4-NitrophenylphosphataseMusclesSkeletal musclebiology.organism_classificationCathepsinsMediusEndocrinologymedicine.anatomical_structurebiology.proteinAcid hydrolasePfl�gers Archiv European Journal of Physiology
researchProduct

Studies on vinblastine-induced autophagocytosis in mouse liver. III. A quantitative study.

1982

The microtubule inhibitor vinblastine (25 mg/kg, i.p.) induces autophagocytosis in mouse hepatocytes. The formation of autophagic vacuoles, their contents, and other cellular changes after vinblastine injection in hepatocytes, were studied by light and electron microscopic morphometric analysis. The volume density of autophagic vacuoles increased significantly during the experimental period (24 h). This increase was due to the significant increase in their number, which was approximately 5-fold 4 h, 12 h and 24 h after vinblastine injection. The mean volume of the autophagic vacuoles increased significantly 1 h after vinblastine injection, at which time the formation of new autophagic vacuo…

Malemedicine.medical_specialtyTime FactorsLiver cytologymedicine.medical_treatmentIntraperitoneal injectionVacuoleBiologyVinblastinesymbols.namesakeMicePhagocytosisInternal medicinemedicineAutophagyAnimalsLobules of liverEndoplasmic reticulumAcid phosphataseGolgi apparatusVinblastineEndocrinologyBiochemistryLiverbiology.proteinsymbolsmedicine.drugVirchows Archiv. B, Cell pathology including molecular pathology
researchProduct

Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report.

2021

Background and objectives: The aim of this study was to report a case of a patient with Charcot-Marie-Tooth disease type 2 (CMT2) treated with epigallocatechin gallate (EGCG) for 4 months in order to assess its therapeutic potential in CMT2. Materials and Methods: The study included a brother and a sister who have CMT2. The sister received 800 mg of EGCG for 4 months, while her brother received placebo for the same period of time. Both participants were assessed before and after daily administration by means of anthropometry; analysis of inflammatory and oxidation markers of interleukin-6 (IL-6) and paraoxonase 1 (PON1) in the blood sample; and motor tests: 2-min walk test (2MWT), 10-m walk…

Malemedicine.medical_specialtyepigallocatechin gallateCase ReportWalk TestDiseaseEpigallocatechin gallatePlaceboCatechinchemistry.chemical_compoundTooth diseaseCharcot-Marie-Tooth DiseaseInternal medicineMedicineHumansCharcot-Marie-Tooth disease type 2lcsh:R5-920IL-6biologyHand Strengthbusiness.industrymotor activityAryldialkylphosphataseParaoxonaseparaoxonase 1General MedicineAnthropometryPON1chemistryWalk testbiology.proteinFemalebusinesslcsh:Medicine (General)
researchProduct

UNC-52/perlecan affects gonadal leader cell migrations in C. elegans hermaphrodites through alterations in growth factor signaling.

2003

0012-1606 doi: DOI: 10.1016/S0012-1606(03)00014-9; The unc-52 gene of Claenorhabditis elegans encodes a homologue of the basement membrane heparan sulfate proteoglycan perlecan. Viable alleles reduce the abundance of UNC-52 in late larval stages and increase the frequency of distal tip cell (DTC) migration defects caused by mutations disrupting the UNC-6/netrin guidance system. These unc-52 alleles do not cause circumferential DTC migration defects in an otherwise wild-type genetic background. The effects of unc-52 mutations on DTC migrations are distinct from effects on myofilament organization and can be partially suppressed by mutations in several genes encoding growth factor-like molecu…

Malemedicine.medical_treatmentOrganogenesisCellDisorders of Sex DevelopmentReceptor-Like Protein Tyrosine PhosphatasesFibroblast growth factorAnimals Genetically ModifiedCell MovementNetrinGrowth SubstancesGenes HelminthGeneticsMusclesCell migrationsWnt signaling pathwayHelminth Proteinsmedicine.anatomical_structurePhenotypeLarvaC. elegansFemaleNetrinsProteoglycansSignal transductionSignal TransductionUNC-52Nerve Tissue ProteinsReceptors Cell SurfacePerlecanmacromolecular substancesBiologymedicineAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsGonadsGeneMolecular BiologyGrowth factorfungiMembrane ProteinsCell BiologyPerlecanReceptors Fibroblast Growth Factornervous systemMutationbiology.proteinProtein Tyrosine PhosphatasesDevelopmental BiologyDevelopmental biology
researchProduct

Overlapping phenotypes between SHORT and Noonan syndromes in patients with PTPN11 pathogenic variants

2020

Overlapping syndromes such as Noonan, Cardio-Facio-Cutaneous, Noonan syndrome (NS) with multiple lentigines and Costello syndromes are genetically heterogeneous conditions sharing a dysregulation of the RAS/mitogen-activated protein kinase (MAPK) pathway and are known collectively as the RASopathies. PTPN11 was the first disease-causing gene identified in NS and remains the more prevalent. We report seven patients from three families presenting heterozygous missense variants in PTPN11 probably responsible for a disease phenotype distinct from the classical Noonan syndrome. The clinical presentation and common features of these seven cases overlap with the SHORT syndrome. The latter is the c…

Malemusculoskeletal diseases0301 basic medicineMAPK/ERK pathwaycongenital hereditary and neonatal diseases and abnormalitiesMAP Kinase Signaling SystemProtein Tyrosine Phosphatase Non-Receptor Type 11030105 genetics & heredityBiologyGene productPhosphatidylinositol 3-Kinases03 medical and health sciencesMetabolic DiseasesGeneticsmedicineHumansMissense mutationskin and connective tissue diseasesProtein kinase BGrowth DisordersGenetics (clinical)GeneticsGenetic heterogeneityNoonan SyndromeGenetic Variationmedicine.diseasePTPN11NephrocalcinosisPhenotype030104 developmental biologySHORT syndromeHypercalcemiaNoonan syndromeFemaleMitogen-Activated Protein KinasesSignal TransductionClinical Genetics
researchProduct

Influence of polymer content in Ca-deficient hydroxyapatite–polycaprolactone nanocomposites on the formation of microvessel-like structures

2009

Calcium phosphate (CaP) ceramics are widely used in bone tissue engineering due to their good osteoconductivity. The mechanical properties of CaP can be modified by the addition of small volume fractions of biodegradable polymers such as polycaprolactone (PCL). Nevertheless, it is also important to evaluate how the polymer content influences cell-material or cell-cell interactions because of potential consequences for bone regeneration and vascularization. In this study we assessed the general biocompatibilty of Ca-deficient hydroxyapatite (CDHA)-PCL disks containing nominally 11 and 24% polycaprolactone using human umbilical vein endothelial cells and human primary osteoblasts. Confocal mi…

Materials scienceAngiogenesisPolyestersBiomedical EngineeringNeovascularization Physiologicchemistry.chemical_elementBiocompatible Materialsmacromolecular substancesCalciumBiochemistryUmbilical veinNanocompositeslaw.inventionBiomaterialschemistry.chemical_compoundConfocal microscopylawHumansBone regenerationMolecular BiologyMicrovesselCell ProliferationOsteoblastsReverse Transcriptase Polymerase Chain Reactiontechnology industry and agricultureEndothelial CellsGeneral MedicineAlkaline Phosphataseequipment and suppliesmusculoskeletal systemBiodegradable polymerCoculture TechniquesDurapatitechemistryMicrovesselsPolycaprolactoneCalciumBiomarkersBiotechnologyBiomedical engineeringActa Biomaterialia
researchProduct

Mesenchymal stem cell proliferation and differentiation on load-bearing trabecular Nitinol scaffolds.

2013

Bone tissue regeneration in load-bearing regions of the body requires high-strength porous scaffolds capable of supporting angiogenesis and osteogenesis. 70% porous Nitinol (NiTi) scaffolds with a regular 3-D architecture resembling trabecular bone were produced from Ni foams using an original reactive vapor infiltration technique. The "trabecular Nitinol" scaffolds possessed a high compressive strength of 79 MPa and high permeability of 6.9×10(-6) cm2. The scaffolds were further modified to produce a near Ni-free surface layer and evaluated in terms of Ni ion release and human mesenchymal stem cell (hMSC) proliferation (AlamarBlue), differentiation (alkaline phosphatase activity, ALP) and …

Materials scienceAngiogenesisSurface PropertiesBiomedical EngineeringNeovascularization PhysiologicBone tissueBiochemistryLoad bearingBiomaterialsExtracellular matrixOsteogenesisMaterials TestingmedicineAlloysHumansMesenchymal stem cell proliferationMolecular BiologyCells CulturedCell ProliferationOsteoblastsTissue ScaffoldsGuided Tissue RegenerationMesenchymal stem cellEndothelial CellsCell DifferentiationMesenchymal Stem CellsGeneral MedicineEquipment DesignEquipment Failure Analysismedicine.anatomical_structureNickel titaniumBone SubstitutesAlkaline phosphataseBiotechnologyBiomedical engineeringActa biomaterialia
researchProduct

Inorganic polymeric phosphate/polyphosphate as an inducer of alkaline phosphatase and a modulator of intracellular Ca2+ level in osteoblasts (SaOS-2 …

2011

Inorganic polymeric phosphate is a physiological polymer that accumulates in bone cells. In the present study osteoblast-like SaOS-2 cells were exposed to this polymer, complexed in a 2:1 stoichiometric ratio with Ca(2+), polyP (Ca(2+) salt). At a concentration of 100 μM, polyP (Ca(2+) salt) caused a strong increase in the activity of the alkaline phosphatase and also an induction of the steady-state expression of the gene encoding this enzyme. Comparative experiments showed that polyP (Ca(2+) salt) can efficiently replace β-glycerophosphate in the in vitro hydroxyapatite (HA) biomineralization assay. In the presence of polyP (Ca(2+) salt) the cells extensively form HA crystallites, which r…

Materials scienceBiomedical EngineeringSalt (chemistry)BiochemistryCell LinePhosphatesBiomaterials03 medical and health scienceschemistry.chemical_compoundBone cellExtracellularHumansMolecular BiologySaos-2 cells030304 developmental biologychemistry.chemical_classification0303 health sciencesOsteoblastsReverse Transcriptase Polymerase Chain ReactionPolyphosphate030302 biochemistry & molecular biologyGeneral MedicinePhosphateAlkaline PhosphataseImmunohistochemistrychemistryBiochemistryEnzyme InductionBiophysicsMicroscopy Electron ScanningAlkaline phosphataseCalciumIntracellularBiotechnologySignal TransductionActa Biomater.
researchProduct

Characterization and osteogenic activity of a silicatein/biosilica-coated chitosan-graft-polycaprolactone.

2014

Several attempts have been made in the past to fabricate hybrid materials that display the complementary properties of the polyester polycaprolactone (PCL) and the polysaccharide chitosan (CHS) for application in the field of bone regeneration and tissue engineering. However, such composites generally have no osteogenic activity per se. Here we report the synthesis of a chitosan-graft-polycaprolactone (CHS-g-PCL) and its subsequent characterization, including crystallinity, chemical structure and thermal stability. Upon surface-functionalization of CHS-g-PCL with osteogenic biosilica via the surface-immobilized enzyme silicatein, protein adsorption, surface morphology and wettability were a…

Materials scienceBone RegenerationPolyestersBiomedical Engineeringmacromolecular substancesBiochemistryBiomaterialsChitosanchemistry.chemical_compoundCrystallinityTissue engineeringCoated Materials BiocompatibleOsteogenesisCell Line TumorHumansComposite materialBone regenerationMolecular BiologyChitosanOsteoblastsintegumentary systemTissue Engineeringtechnology industry and agricultureGeneral Medicinemusculoskeletal systemequipment and suppliesAlkaline PhosphataseSilicon DioxidePolyesterchemistryChemical engineeringPolycaprolactoneHybrid materialBiotechnologyProtein adsorptionActa biomaterialia
researchProduct